• Simple blood test
  • Full or critical exon coverage of 74 genes + MSI status from Circulating Tumour DNA (ctDNA)
  • Includes full range of genetic mutations:
    • single nucleotide variations (SNVs)
    • insertions/deletions (INDELs)
    • copy number alterations (CNAs)
    • fusions
    • microsatellite instability status (MSI)
  • Proprietary published targeted digital DNA sequencing method
  • Real time information (ctDNA 90 minute half life)
  • Published quality metrics:
    • robust assay with low failure rate (<1%)
    • high sensitivity across range of mutant allele
      fractions (MAF)
    • very high specificity
    • strong correlation with tissue biomarkers
    • Clinical response map with serial blood tests over time
    • Identifies FDA approved therapies and available clinical trials

Insurance cover


Please discuss with your
Insurance Provider
Tests covered by the PartnersLife Cancer Testing Benefit schedule

Our Partner

Enquire about a test

Testing is by referral from an Oncologist, medical or surgical specialist.
If you want more information, click on the button below.

Contact Us

Copyright by BoldThemes 2018. All rights reserved.